fashion -WSS

fashion

author：comprehensive 2025-09-04 04:25:45 - browse：2

Fatty liver foregrounds arteries and veins surrounded by red blood cells — health coverage from STAT — Adobe

As drugmakers race to join the obesity drug market ignited by the approval of Wegovy and Zepbound, they’re not just competing on their drugs’ weight loss effects. They’re also competing on their products’ ability to treat a severe form of liver disease.

A new update of the STAT Obesity Drug Tracker shows that at least 23 — about one-fifth — of the 105 obesity treatments in development or on the market are also being investigated for metabolic dysfunction-associated steatohepatitis, the fatty liver disease known as MASH (and previously called NASH).

In this update, STAT has added a category — “other diseases investigated” — to show conditions beyond obesity for which a compound is being studied. Type 2 diabetes is the most common – it’s long been linked to obesity, and the latest GLP-1 treatments like Wegovy and Zepbound were initially developed as diabetes drugs. But behind diabetes, the next most common disease under investigation for obesity candidates is MASH.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Generative AI mines health records to identify patients’ social needs

explore

WSS

North Korean leader's powerful sister says warplanes repelled US spy plane

House panel to mark up pandemic

Why Titanic fascinates society, still drawing tours to the wreckage

The PBM ad wars are taking over Washington, D.C.

JPM 2024: FogPharma’s CEO unveils ‘contrarian’ plan in oncology

As JPM 2024 winds down, some health tech firms project optimism

explore

fashion

hotspot

BioMarin wins approval for gene therapy to treat hemophilia A

Father who lunged at Larry Nassar comforted by deputy who pinned him down: 'I understand'

United colonoscopy coverage change 'may cost lives,' doctors say

Drinking water from half of US faucets contains PFAS: Study

New air purifier tech could be key to improving indoor air quality

Idaho abortion case may prompt more restrictions in other states

Walensky prepares to leave CDC — and Congress — behind

North Korean leader's powerful sister says warplanes repelled US spy plane

Bright Health sells Medicare Advantage business to Molina

Why Titanic fascinates society, still drawing tours to the wreckage

hotspot

Tennessee woman gets emergency hysterectomy after doctors deny early abortion care

Drinking water from half of US faucets contains PFAS: Study

What to know about a major upcoming Wegovy heart health study

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

How corporate America is slashing DEI workers amid backlash to diversity programs

Trump seeks lengthy delay of classified docs trial, citing upcoming election

entertainment

focus

explore

entertainment